Thursday 21st May 2020
|Text too small?|
Some of the largest shareholders in Metlifecare Limited (NZX: MET , ASX: MEQ), representing one third of the shares on issue, have already confirmed their strong support for the actions taken by the Board to compel Asia Pacific Village Group Limited (APVG) to fulfil its contractual obligations under the Scheme Implementation Agreement (SIA) entered on 29 December 2019. APVG is an entity owned by EQT Infrastructure IV fund and managed by EQT Fund Management S.à.r.l..
The Guardians of the New Zealand Superannuation Fund, the Accident Compensation Corporation and overseas-based investors Maso Capital, Omni Partners and Westchester Capital, which together represent economic or beneficial ownership exceeding 33.4 per cent of Metlifecare shares, have endorsed through written confirmations provided to Metlifecare the recent decision by the Board of Metlifecare to file a Statement of Claim in the High Court of New Zealand to challenge the validity of APVG’s notice to terminate the SIA.
The shareholders each also confirmed that it was their current intention1 to vote in favour of the scheme plan if it is put to shareholders.
Metlifecare Chairman Kim Ellis said: “We welcome the support of our major shareholders for court action we should never have been forced to take. Like them, the Board of Metlifecare remains strongly committed to the successful completion of the Scheme and hopes this matter can be resolved quickly and equitably for the benefit of Metlifecare and its shareholders.”
Metlifecare filed the Statement of Claim on 15 May 2020. The matter is expected to initially be heard in the High Court on 28 May 2020, at which time Metlifecare will make a request for an expedited court timetable.
The proceeding reiterates the reasons why Metlifecare considers there is no lawful basis to terminate the SIA, namely that no Material Adverse Change has occurred and that there have been no prescribed occurrences that would permit APVG to terminate the SIA. Metlifecare is seeking orders to compel APVG and the EQT Infrastructure IV fund to fulfil their obligations under the SIA and an Equity Commitment Letter.
The 28 May hearing will also consider Metlifecare’s separate proceeding applying for initial orders to call a meeting of its shareholders to vote on the scheme plan contemplated by the SIA. Subject to the approval of the court, Metlifecare anticipates holding the shareholder meeting to consider the scheme plan in late June or early July.
Metlifecare shareholders do not need to take any action at this time.
Source: Metlifecare Limited.
No comments yet
Talisman Quarterly Activities Report to 30 June 2020
General Capital gives notice of Annual Meeting
Scales Corporation - Business Update
Fonterra Co-operative Group Global Dairy Update
Fonterra revises its 2019/20 and 2020/21 forecast Farmgate Milk Price ranges
Briscoe Group Limited Market update: 2nd Quarter Sales to 26 July 2020
thl market update - A frame work for 2021
Me Today - Outcome Of Share Purchase Plan Offer
Maxigesic IV® licensed in six new European nations
Evolve Shareholder Update